Treadwell Therapeutics
Developing novel therapeutics for highly aggressive cancers by targeting critical tumor-specific vulnerabilities including aneuploidy and immunogenicity. Learn more
Launch date
Employees
Market cap
-
Enterprise valuation
€331—496m (Dealroom.co estimates Nov 2021.)
New York City New York (HQ)
Authorizing premium user...